Mitoxantrone and paclitaxel combination chemotherapy in metastatic breast cancer.

Harvey, J; Cantrell, J; Campbell, M; Cartmell, A; Urba, W; Modiano, M; Schuster, M; Rubin, A; Newcomb, T; Ghalie, R

Harvey, J; Cantrell, J; Campbell, M; Cartmell, A; Urba, W; Modiano, M; Schuster, M; Rubin, A; Newcomb, T; Ghalie, R.

Affiliation

Harvey J; Bruno Cancer Baptist Medical Center, Birmingham, Alabama, USA.

Cancer Invest ; 19(3): 225-33, 2001.

Article in En | MEDLINE | ID: mdl-11338878

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/pathology; Disease Progression; Disease-Free Survival; Female; Humans; Infusions, Intravenous; Middle Aged; Mitoxantrone/administration & dosage; Neoplasm Metastasis; Neutropenia/chemically induced; Paclitaxel/administration & dosage; Prognosis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Cancer Invest Year: 2001 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links